Naltrekson: interakcje

Opioid Antagonist: Naloxegol ↑ naloxegol Avoid use with BIXLENVO; if unavoidable, decrease the dosage of naloxegol and monitor for adverse reactions. (etykieta leku Biktegrawir + emtrycytabina + alafenamid tenofowiru, Interakcje z innymi lekami)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Any individual who has failed the naloxone challenge test or has a positive urine screen for opioids [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

John's wort ( Hypericum perforatum ) Hepatitis C direct acting antiviral: elbasvir/grazoprevir Lipid modifying agents: lomitapide, lovastatin, simvastatin Opioid Antagonist: naloxegol PDE-5 inhibitor: sildenafil when used for treatment of pulmonary arterial hypertension Sedatives/hypnotics: orally administered midazolam, triazolam Co-administration of PREZISTA/ritonavir… (etykieta leku Darunawir, Przeciwwskazania)

John's wort ( Hypericum perforatum ) Hepatitis C direct acting antiviral: elbasvir/grazoprevir Lipid modifying agents: lomitapide, lovastatin, simvastatin Opioid Antagonist: naloxegol PDE-5 inhibitor: sildenafil when used for treatment of pulmonary arterial hypertension Sedatives/hypnotics: orally administered midazolam, triazolam PREZCOBIX or PREZCOBIX PED is… (etykieta leku Darunawir + kobicystat, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Opioid Antagonist: naloxegol ↑ naloxegol Avoid use with SUNLENCA; if unavoidable, decrease the dosage of naloxegol and monitor for adverse reactions. (etykieta leku Lenakapawir, Interakcje z innymi lekami)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

• Other Opioid Antagonists : Potential for additive effect and increased risk of opioid withdrawal; avoid concomitant use. (etykieta leku Metylonaltrekson, Interakcje z innymi lekami)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Intervention Avoid use of SYMPROIC with another opioid antagonist. (etykieta leku Naldemedyna, Interakcje z innymi lekami)

Other opioid antagonists : Potential for additive effect and increased risk of opioid withdrawal; avoid concomitant use. (etykieta leku Naloksegol, Interakcje z innymi lekami)

Any individual who has failed the naloxone challenge test or has a positive urine screen for opioids [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

…Migraine medications: eletriptan, ubrogepant • Mineralocorticoid receptor antagonists: finerenone • Non-opioid analgesic (selective blocker of Na v 1.8 sodium channels): suzetrigine • Opioid antagonists: naloxegol • PDE5 inhibitor: sildenafil (Revatio ® ) when used for pulmonary arterial hypertension (PAH) • Sedative/hypnotics: triazolam, oral midazolam • Serotonin… (etykieta leku Nirmatrelwir + rytonawir, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Any individual who has failed the naloxone challenge test or has a positive urine screen for opioids [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Naltrexone for extended-release injectable suspension is contraindicated in: Patients receiving opioid analgesics [see Warnings and Precautions ( 5.3 ) ] . (etykieta leku Naltrekson, Przeciwwskazania)

Narcotic analgesics/treatment of opioid dependence: buprenorphine buprenorphine/naloxone methadone ↔ etravirine ↓ buprenorphine ↔ norbuprenorphine ↔ methadone Etravirine and buprenorphine (or buprenorphine/naloxone) can be co-administered without dose adjustments, however, clinical monitoring for withdrawal symptoms is recommended as buprenorphine (or buprenorphine/naloxone)… (etykieta leku Etrawiryna, Interakcje z innymi lekami)

Oral Naltrexone : Concomitant use may reduce efficacy of oral naltrexone. (etykieta leku Lofeksydyna, Interakcje z innymi lekami)

Strongly consider recommending or prescribing an opioid reversal agent (e.g., naloxone, nalmefene) for the emergency treatment of opioid overdose (5.1) . (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Precipitation of Opioid Withdrawal : Opioid-dependent and opioid-using patients, including those being treated for alcohol dependence, should be opioid-free before starting naltrexone for extended-release injectable suspension treatment, and should notify healthcare providers of any recent opioid use. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

The opioid therapy must be provided by individuals specifically trained in the use of anesthetic drugs and the management of the respiratory effects of potent opioids, specifically the establishment and maintenance of a patent airway and assisted ventilation. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

The opioid therapy must be provided by individuals specifically trained in the use of anesthetic drugs and the management of the respiratory effects of potent opioids, specifically the establishment and maintenance of a patent airway and assisted ventilation. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

The opioid therapy must be provided by individuals specifically trained in the use of anesthetic drugs and the management of the respiratory effects of potent opioids, specifically the establishment and maintenance of a patent airway and assisted ventilation. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

The opioid therapy must be provided by individuals specifically trained in the use of anesthetic drugs and the management of the respiratory effects of potent opioids, specifically the establishment and maintenance of a patent airway and assisted ventilation. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

The opioid therapy must be provided by individuals specifically trained in the use of anesthetic drugs and the management of the respiratory effects of potent opioids, specifically the establishment and maintenance of a patent airway and assisted ventilation. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

The opioid therapy must be provided by individuals specifically trained in the use of anesthetic drugs and the management of the respiratory effects of potent opioids, specifically the establishment and maintenance of a patent airway and assisted ventilation. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

The opioid therapy must be provided by individuals specifically trained in the use of anesthetic drugs and the management of the respiratory effects of potent opioids, specifically the establishment and maintenance of a patent airway and assisted ventilation. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (etykieta leku Naltrekson, Ostrzeżenia i środki ostrożności)

The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (etykieta leku Akamprozat, Interakcje z innymi lekami)

Narcotic Analgesics: buprenorphine/ naloxone ↑ buprenorphine ↑ norbuprenorphine ↓ naloxone No dosage adjustment of buprenorphine/naloxone is required upon coadministration with GENVOYA. (etykieta leku Elwitegrawir + kobicystat + emtrycytabina + tenofowir, Interakcje z innymi lekami)

No clinically significant drug interactions have been either observed or are expected when DESCOVY is combined with the following drugs: buprenorphine, itraconazole, ketoconazole, lorazepam, methadone, midazolam, naloxone, norbuprenorphine, norgestimate/ethinyl estradiol, and sertraline. (etykieta leku Emtrycytabina + tenofowir, Interakcje z innymi lekami)